TRCT
BNTX icon

Tower Research Capital (TRC)’s BioNTech BNTX Stock Holding History

Tower Research Capital (TRC)’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222K Buy
+2,384
New +$224K 0.01% 1615
2026
Q1 		– Sell
-84
Closed -$8K – 5144
2025
Q4 		$8K Sell
84
-1,324
-94% -$133K ﹤0.01% 3972
2025
Q3 		$139K Buy
1,408
+845
+150% +$90.3K ﹤0.01% 1756
2025
Q2 		$59.9K Buy
563
+305
+118% +$30.8K ﹤0.01% 2814
2025
Q1 		$23.5K Sell
258
-1,623
-86% -$182K ﹤0.01% 2816
2024
Q4 		$214K Buy
1,881
+713
+61% +$81.4K ﹤0.01% 1669
2024
Q3 		$139K Sell
1,168
-10,515
-90% -$967K ﹤0.01% 1961
2024
Q2 		$939K Buy
11,683
+7,220
+162% +$660K 0.02% 813
2024
Q1 		$412K Buy
4,463
+1,475
+49% +$141K 0.01% 975
2023
Q4 		$315K Buy
2,988
+523
+21% +$52.7K ﹤0.01% 1742
2023
Q3 		$268K Sell
2,465
-18,763
-88% -$2.08M 0.01% 1252
2023
Q2 		$2.29M Buy
21,228
+21,221
+303,157% +$2.39M 0.08% 202
2023
Q1 		$1K Sell
7
-1,503
-100% -$206K ﹤0.01% 5499
2022
Q4 		$227K Buy
1,510
+105
+7% +$16.2K 0.01% 1223
2022
Q3 		$190K Sell
1,405
-9,872
-88% -$1.51M ﹤0.01% 1985
2022
Q2 		$1.68M Buy
11,277
+4,988
+79% +$762K 0.04% 432
2022
Q1 		$1.07M Buy
6,289
+3,829
+156% +$643K 0.01% 760
2021
Q4 		$634K Sell
2,460
-2,722
-53% -$745K 0.01% 959
2021
Q3 		$1.42M Sell
5,182
-9,964
-66% -$3.17M 0.04% 367
2021
Q2 		$3.39M Buy
15,146
+14,538
+2,391% +$2.74M 0.09% 165
2021
Q1 		$66K Sell
608
-8,351
-93% -$887K ﹤0.01% 2893
2020
Q4 		$730K Buy
8,959
+5,823
+186% +$572K 0.02% 706
2020
Q3 		$217K Buy
3,136
+3,042
+3,236% +$218K ﹤0.01% 2501
2020
Q2 		$6K Buy
+94
New +$4.69K ﹤0.01% 4201

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Tower Research Capital (TRC)'s BNTX Position: Q2 2026 in Review

Tower Research Capital (TRC) opened a new position in BioNTech (BNTX) in Q2 2026: 2,384 shares worth $222K. The stake represents 0.01% of the portfolio and ranks #1615 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in BNTX as recently as Q4 2025.

Tower Research Capital (TRC) first reported a position in BNTX in Q2 2020 and has held it in 24 quarters since. The position peaked at $3.39M in Q2 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Tower Research Capital (TRC) held 2,384 shares of BioNTech worth $222K as of Q2 2026.
  • BioNTech was a new Tower Research Capital (TRC) position in Q2 2026.
  • BioNTech made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #1615 holding.
  • Tower Research Capital (TRC) first reported a position in BioNTech in Q2 2020 and has held it in 24 quarters since.
  • Tower Research Capital (TRC)'s BioNTech position peaked at $3.39M in Q2 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.